NYSE$CLB
Core Laboratories Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
Core Laboratories Inc reported flat revenue and higher net income for Q2 2025 compared to the prior year.
Core Laboratories Inc achieved total revenue of $130.2 million in Q2 2025, essentially unchanged year-over-year, with operating income of $15.3 million. Net income attributable to the company rose to $10.6 million, or $0.23 per diluted share. The company maintained strong international project activity while navigating U.S. onshore softness and geopolitical impacts on crude assay services.
- Q2 revenue held steady at $130.2 million year-over-year, with Reservoir Description at $86.3 million and Production Enhancement at $43.9 million.
- Net income attributable to Core Laboratories Inc. increased 18% to $10.6 million, supported by lower interest expense and a reduced effective tax rate.
- Cash and cash equivalents rose to $31.2 million at quarter end, aided by $20.6 million in operating cash flow for the first half of 2025.
- The company declared a quarterly dividend of $0.01 per share and repurchased 369,230 shares year-to-date for $4.8 million.
Headline financials
Revenue & EPS history
Core Labs · Revenue · Quarterly
$130M
Revenue by segment
Core Labs · $130M total across 2 segments · Q2 2025
- Reservoir Description$86.3M—66.3%
- Production Enhancement$43.9M—33.7%
Forward guidance
Global crude oil demand is expected to rise in 2025 and beyond, but near-term uncertainty from tariffs, OPEC+ production increases and geopolitical conflicts may pressure short-cycle U.S. activity while large international projects remain resilient.
Tailwinds
- Large-scale international and offshore projects continue as planned.
- Growing client investment in carbon capture, utilization and storage.
- Value-focused operators form the core client base and support technology-driven work.
Headwinds
- OPEC+ gradual production increases and potential inventory builds may weigh on crude prices.
- U.S. onshore drilling and completion activity is sensitive to price volatility.
- Geopolitical sanctions continue to disrupt crude trading and assay service demand.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 9 quarterly earnings reports
+4.1%
Avg return
Earnings day
+2.8%
Avg return
5 days after
-3.7%
Avg return
30 days after
67%
6 / 9 earnings
Positive
+28.8%
Q3 2025
Best reaction
-15.3%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -15.3% | -17.7% | -21.2% | |
| Q4 2025 | -4.2% | -4.9% | -18.9% | |
| Q3 2025 | +28.8% | +29.0% | +15.3% | |
| Q1 2025 | +2.2% | -2.1% | -6.5% | |
| Q3 2024 | +10.9% | +14.2% | +24.6% | |
| Q2 2024 | +10.6% | +11.2% | -16.6% | |
| Q1 2024 | +3.3% | -4.4% | +8.4% | |
| Q3 2023 | +1.1% | -10.8% | -14.0% | |
| Q2 2023 | -0.8% | +10.6% | -4.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro